Effect of topical recombinant human epidermal growth factor on chronic diabetic ulcer compared with conventional saline dressing
Phase 3
- Conditions
- Health Condition 1: - Health Condition 2: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/05/067239
- Lead Sponsor
- Dr A Sneha Daffodil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Grade 1 and 2 wagners classification
ulcer duration more than 3 weeks
able to understand the merits and demerits of both the procedure and provide consent
Exclusion Criteria
Age less than 18 years and more than 80 years 2.Patient with cardiac disease,HIV,Hepatitis, pregnancy and critically ill patients 3.Chronic venous/Aretrial ulcers 4.Malignant ulcers 5.Anemia( <7gm/dl) 6.Known or Suspected osteomyelitis 7.Ulcer is less than 2cm.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method